Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90

被引:356
作者
Schneider, C
SeppLorenzino, L
Nimmesgern, E
Ouerfelli, O
Danishefsky, S
Rosen, N
Hartl, FU
机构
[1] MEM SLOAN KETTERING CANC CTR, HOWARD HUGHES MED INST, NEW YORK, NY 10021 USA
[2] MEM SLOAN KETTERING CANC CTR, CELLULAR BIOCHEM & BIOPHYS PROGRAM, NEW YORK, NY 10021 USA
[3] MEM SLOAN KETTERING CANC CTR, CELL BIOL & GENET PROGRAM, NEW YORK, NY 10021 USA
[4] MEM SLOAN KETTERING CANC CTR, GM OBRIEN UROL RES CTR, DEPT MED, NEW YORK, NY 10021 USA
关键词
D O I
10.1073/pnas.93.25.14536
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The role of the abundant stress protein Hsp90 in protecting cells against stress-induced damage is not Hell understood, The recent discovery that a class of ansamycin antibiotics bind specifically to Hsp90 allowed us to address this problem from a new angle, We find that mammalian Hsp90, in cooperation with Hsp70, p60, and other factors, mediates the ATP-dependent refolding of heat-denatured proteins, such as firefly luciferase. Failure to refold results in proteolysis. The ansamycins inhibit refolding, both in vivo and in a cell extract, by preventing normal dissociation of Hsp90 from luciferase, causing its enhanced degradation, This mechanism also explains the ansamycin-induced proteolysis of several protooncogenic protein kinases. such as Raf-1, which interact with Hsp90. We propose that Hsp90 is part of a quality control system that facilitates protein refolding or degradation during recovery from stress, This function is used by a limited set of signal transduction molecules for their folding and regulation under nonstress renditions, The ansamycins shift the mode of Hsp90 from refolding to degradation, and this effect is probably amplified fur specific Hsp90 substrates.
引用
收藏
页码:14536 / 14541
页数:6
相关论文
共 33 条